PetLife Pharmaceuticals, Inc. Proceeds from Convertible Debt
PetLife Pharmaceuticals, Inc. reported Proceeds from Convertible Debt of $270.00 thousand for the 6-month period ending 2018-02-28, per its 10-Q filed 2018-07-17.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2018-07-17
- PetLife Pharmaceuticals, Inc. proceeds from convertible debt for the quarter ending 2017-08-31 was $128.00K.
- PetLife Pharmaceuticals, Inc. proceeds from convertible debt for the quarter ending 2017-05-31 was $0.00.
- PetLife Pharmaceuticals, Inc. proceeds from convertible debt for fiscal 2017 was $220.50K.
| Period end | Proceeds from Convertible Debt 3 month | Proceeds from Convertible Debt 6 month | Proceeds from Convertible Debt 9 month | Proceeds from Convertible Debt 12 month |
|---|---|---|---|---|
| 2018-02-28 | $270.00K 10-Q · filed 2018-07-17 | |||
| 2017-08-31 | $128.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-15 | $128.00K derived: sum of 2 quarters · filed 2017-12-15 | $220.50K 10-K · filed 2017-12-15 | |
| 2017-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-07-18 | $92.50K 10-Q · filed 2017-07-18 | ||
| 2017-02-28 | $92.50K 10-Q · filed 2018-07-17 |